Benjamin Thayer
Family Medicine · Lincoln, NENPI 1780979195
Payments from drug & device makers
Across 149 payments — averaging $16.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$854
- Novo Nordisk$213
- Pfizer$193
- Amgen$180
- Supernus Pharmaceuticals, Inc.$112
- AstraZeneca$108
- plus $766 from 19 others
What the payments were for
- Food & beverage$2,426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $854 |
| Novo Nordisk | 15 | $213 |
| Pfizer | 13 | $193 |
| Amgen | 13 | $180 |
| Supernus Pharmaceuticals, Inc. | 3 | $112 |
| AstraZeneca | 8 | $108 |
| Novartis | 6 | $97 |
| Bayer | 5 | $91 |
| Kowa Pharmaceuticals America, Inc. | 6 | $81 |
| Lilly USA, LLC | 6 | $80 |
| Sunovion Pharmaceuticals Inc. | 7 | $49 |
| Boehringer Ingelheim | 3 | $45 |
| Astellas Pharma US Inc | 2 | $44 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Merck | 3 | $42 |
| Medtronic | 1 | $35 |
| Johnson & Johnson | 2 | $25 |
| Abbott | 1 | $24 |
| Antares Pharma, Inc. | 1 | $20 |
| Organon | 1 | $20 |
| Lundbeck LLC | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$2,426 in reported general payments places this provider in the 75th percentile of 981 family medicine providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 80 | $82,895 |
| JardianceEmpagliflozin | 61 | $62,927 |
| EliquisApixaban | 53 | $37,044 |
| Nurtec OdtRimegepant Sulfate | 11 | $22,096 |
| FarxigaDapagliflozin Propanediol | 26 | $20,629 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $19,828 |
| SynjardyEmpagliflozin/Metformin Hcl | 22 | $16,780 |
| TrulicityDulaglutide | 12 | $11,624 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 24 | $11,153 |
| MyrbetriqMirabegron | 16 | $10,981 |
| Xigduo XrDapaglifloz Propaned/Metformin | 16 | $10,308 |
| EntrestoSacubitril/Valsartan | 14 | $9,937 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,596 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $8,493 |
| Repatha SureclickEvolocumab | 11 | $6,386 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $213 | $82,89580 claims |
| Boehringer IngelheimJardiance, Synjardy | $45 | $79,70783 claims |
| PfizerEliquis, Nurtec Odt | $193 | $59,14164 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $108 | $34,19356 claims |
| Lilly USA, LLCTrulicity, Olanzapine | $80 | $12,91926 claims |
| Astellas Pharma US IncMyrbetriq | $44 | $10,98116 claims |
| NovartisEntresto | $97 | $9,93714 claims |
| Johnson & JohnsonInvokana | $25 | $5,82311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 981 family medicine providers in Nebraska.
Other family medicine in Lincoln
- Allen HuntLincoln$17.2M
- Michael IsraelLincoln$375K
- Randy KohlLincoln$67K
- Matthew GlennLincoln$17K
- Uma NookaLincoln$12K
- Kylie ParshallLincoln$12K
- Michael HuffmanLincoln$11K
- Svjetlana DzikoLincoln$11K
- Eric JohnsonLincoln$10K
- Gary van ErtLincoln$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.